Trial intelligence / Profile preview

Oral Cholera Vaccine Effects on Gut Health in Healthy Adults

NCT07873346Phase 4Not yet recruiting

Start
Oct 2026
Primary completion
Jun 2027
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cholera. Primary endpoints: Change in gut microbiota alpha diversity, beta diversity, and microbial composition and Bowel habits. Planned start Oct 2026; status: not yet recruiting.

02

Conditions

cholera

Beyond the preview

Go deeper on NCT07873346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07873346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call